EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Non-inferior outcome of abbreviated R-CHOP in patients with stage I primary testicular lymphoma

Diana Al-Sarayfi, Johanna A A Bult, Ruben A L de Groen, Fleur A de Groot, Joost S P Vermaat, Djamilla Issa, Arjan Diepstra, Gerwin Huls, Mar Bellido, Wouter Plattel, Mirian Brink, Marcel Nijland

European Journal of Cancer · 2025

DOI: 10.1016/j.ejca.2025.115776 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Diana Al-Sarayfi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of hematology, University Medical Center Groningen, Groningen, the Netherlands. Hauptthemen laut MEDLINE: Testicular Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Lymphoma, Large B-Cell, Diffuse. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Testicular NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsLymphoma, Large B-Cell, DiffuseHumansMaleRituximabPrednisoneAgedCyclophosphamideVincristineDoxorubicinMiddle AgedNeoplasm StagingAged, 80 and overAdultTreatment OutcomeAntibodies, Monoclonal, Murine-DerivedNetherlands

Stichwörter der Autor:innen

Population-basedPrimary testicular lymphomaR-CHOPSurvival

Substanzen

RituximabPrednisoneCyclophosphamideVincristineDoxorubicinR-CHOP protocolAntibodies, Monoclonal, Murine-Derived

Autor:innen und Institutionen

  • Department of hematology, University Medical Center Groningen, Groningen, the Netherlands.
  • Department of hematology, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of hematology, Jeroen Bosch Hospital, 's Hertogenbosch, the Netherlands.
  • Department of pathology and Medical Biology, University Medical Center Groningen, Groningen, the Netherlands.
  • Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.
  • Department of hematology, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: m.nijland@umcg.nl.

Zitieren

APA

Al-Sarayfi, D., Bult, J. A. A., de Groen, R. A. L., de Groot, F. A., Vermaat, J. S. P., Issa, D., Diepstra, A., Huls, G., Bellido, M., Plattel, W., Brink, M., & Nijland, M. (2025). Non-inferior outcome of abbreviated R-CHOP in patients with stage I primary testicular lymphoma. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115776

Vancouver

Al-Sarayfi D, Bult JAA, de Groen RAL, de Groot FA, Vermaat JSP, Issa D, et al. Non-inferior outcome of abbreviated R-CHOP in patients with stage I primary testicular lymphoma. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.115776

BibTeX
@article{AlSarayfi2025,
  author = {Al-Sarayfi, Diana and Bult, Johanna A A and de Groen, Ruben A L and de Groot, Fleur A and Vermaat, Joost S P and Issa, Djamilla and Diepstra, Arjan and Huls, Gerwin and Bellido, Mar and Plattel, Wouter and Brink, Mirian and Nijland, Marcel},
  title = {Non-inferior outcome of abbreviated R-CHOP in patients with stage I primary testicular lymphoma},
  journal = {European Journal of Cancer},
  year = {2025},
  doi = {10.1016/j.ejca.2025.115776}
}
Kostenlos starten →